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Abstract
The current secondary structure model of the Na/dicarboxylate cotransporter, NaDC-1, contains 11 transmembrane
domains. The model is based on hydropathy analysis and the extracellular location of the carboxy terminus, which contains
an N-glycosylation site. In this study, the model was further tested using indirect immunofluorescence of COS-7 cells. The
Flag epitope tag (DYKDDDDK) was fused to the amino terminus of NaDC-1 (Flag-NaDC-1), and a monoclonal antibody
against the Flag epitope was used to determine the location of the N-terminus. Hydrophilic loop 4 of NaDC-1 was identified
using polyclonal antibodies raised against a fusion protein containing amino acids 164^233 of NaDC-1. The expression of
NaDC-1 and Flag-NaDC-1 in COS-7 cells was confirmed by functional assays of succinate transport and by Western blots of
cell surface biotinylated proteins. Immunofluorescent labeling of cells expressing both NaDC-1 and Flag-NaDC-1 required
permeabilization of the plasma membranes with digitonin whereas no immunofluorescence was visible in intact cells. The
results of this study show that both the N-terminus and hydrophilic loop 4 of NaDC-1 are located intracellularly, which
supports the current model of NaDC-1 structure. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Metabolic intermediates of the citric acid cycle,
including succinate and citrate, are reabsorbed in
the renal proximal tubule by a sodium-coupled trans-
porter called NaDC-1 (Na/dicarboxylate cotrans-
porter 1) [1,2]. NaDC-1 has a broad substrate selec-
tivity for a range of di- and tricarboxylates that are
carried as divalent anions. The primary function of
NaDC-1 in the kidney is to ¢lter citric acid cycle
intermediates, which are then metabolized within
the proximal tubule cells or are used for exchange
with organic anions during organic anion secretion
[1]. An important role of NaDC-1 is the regulation
of the concentration of urinary citrate, which acts as
a calcium chelator. Hypocitraturia has been impli-
cated as a risk factor in the development of kidney
stones [3].
NaDC-1 belongs to a distinct superfamily of so-
dium-coupled anion transporters, called SLC13 in
the human gene nomenclature [1]. The family con-
tains several orthologues of NaDC-1 from rabbit,
human, rat and mouse [4^7]. NaDC-2, from Xenopus
intestine, is approx. 62% identical to rabbit NaDC-1
(rbNaDC-1) and it transports both sodium and lith-
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ium [8]. The high a⁄nity Na/dicarboxylate cotrans-
porters, NaDC-3, from rat, human, and winter
£ounder are approx. 43% identical to rbNaDC-1
[9^11]. The SLC13 family also contains the Na/sul-
fate cotransporters, NaSi-1 and SUT-1, which are
approx. 40% identical in sequence to rbNaDC-1
[12^14].
The secondary structure model of NaDC-1 con-
tains 11 transmembrane domains and an extracellu-
lar carboxy terminus [15]. All of the members of the
SLC13 family contain a conserved N-glycosylation
consensus sequence at the carboxy terminus. This
site is glycosylated in NaDC-1, which places the C-
terminus on the outside of the cell [15]. However,
several alternate secondary structure models, con-
taining eight, 12 or 13 transmembrane domains,
have been proposed for the transporters related to
NaDC-1 [9,13,16]. In this study, the secondary struc-
ture model of NaDC-1 is tested further using immu-
no£uorescence of COS-7 cells expressing NaDC-1
and a construct of NaDC-1 containing an epitope
tag at the N-terminus, called Flag-NaDC-1. The re-
sults show that both the N-terminus and hydrophilic
loop 4 are located intracellularly, which supports the
current model of NaDC-1 topology.
2. Methods
2.1. Construction of Flag-NaDC-1
The N-terminus of the rabbit NaDC-1 was fused
with the peptide DYKDDDDK, containing the epi-
tope of the Flag monoclonal antibody, to form the
Flag-NaDC-1 fusion protein. The epitope tag al-
lowed immunological localization of the N-terminus
of NaDC-1. The fusion protein was constructed us-
ing polymerase chain reaction (PCR), with a sense
primer similar to that used for the Na/I3 symporter
[17]. The sequence of the sense oligonucleotide used
in the PCR was 5P-G GAA TTC ATG GAC TAC
AAG GAC GAC GAT GAC AAA GCC ACC TGC
TGG CAG GGC CTG-3P, which contains an EcoRI
restriction site, a start codon, the nucleotides coding
for the eight amino acid Flag peptide, followed by 21
nucleotides of the 5P end of NaDC-1 coding for ami-
no acids 2^8. The antisense primer was complimen-
tary to nucleotides 841^862 of NaDC-1. The tem-
plate for the PCR ampli¢cation was the plasmid
pSV-201 containing the coding region of the rabbit
NaDC-1 in the pSV-SPORT1 expression vector [18].
The PCR reaction was run using the Failsafe PCR
kit (Epicenter Technologies) with the following
cycles: a denaturation step of 1 min at 95‡C, fol-
lowed by 25 two-step reaction cycles (95‡CU1 min,
72‡CU2 min), and a ¢nal 15 min elongation step at
72‡C. The resulting PCR fragment was cloned into
the pCR2.1 vector (InVitrogen) and a 575 nucleotide
EcoRI-SacI fragment of the insert was subsequently
subcloned into the EcoRI and SacI sites of plasmid
pSV-201. The ¢nal construct was called pSV-201-
Flag. The identity of the ampli¢ed cDNA was veri-
¢ed by sequencing.
2.2. Transient transfections of COS-7 cells
COS-7 cells (CRL 1651) were used for expression
of NaDC-1 and Flag-NaDC-1 in this study. Cells
were cultured in Dulbecco’s modi¢ed Eagle’s me-
dium (D-MEM) containing 4.5 g/l glucose, 25 mM
HEPES, 10% heat-inactivated fetal calf serum and
1% antibiotic-antimycotic (Gibco/BRL), in 10%
CO2 at 37‡C as described in our previous study
[18]. One day prior to transfection, cells were seeded
at a density of 5U105 cells per well of a six-well
plastic dish (immuno£uorescence, Western blots) or
2U105 cells per well of a 12-well dish (transport as-
says). For immuno£uorescence experiments, the cells
were plated onto 22 mm2 glass coverslips placed into
each well. The cells were transfected using the Gene-
PORTER protocol (GTS) following the manufac-
turer’s directions. Brie£y, the transfection mixture
contained 4 Wg of plasmid DNA and 15 Wl of Gene-
PORTER transfection reagent per ml D-MEM me-
dium (without serum or antibiotics). The six-well
plates were transfected with 1 ml of the transfection
mixture per well and the 12-well plates were trans-
fected with 0.5 ml of the transfection mixture per
well. Experimental groups were transfected with
pSV-201 or pSV-201-Flag whereas control groups
were transfected with pSV-SPORT1 vector or with
the transfection reagent only. Duplicate or triplicate
wells were transfected for each group. All of the ex-
periments were carried out at 48 h after transfection,
since our previous study showed peak expression of
NaDC-1 at that time [18].
BBAMEM 78044 1-3-01
F.F. Zhang, A.M. Pajor / Biochimica et Biophysica Acta 1511 (2001) 80^89 81
2.3. Succinate transport assay
The transport of [3H]succinate was measured in
COS-7 cells transfected with pSV-201, pSV-201-
Flag or the control plasmid, pSV-SPORT1, using a
modi¢cation of our previous protocol [18]. The
transport bu¡ers and washing solutions were added
to each well of a plate simultaneously using specially
constructed manifolds made from culture plate tops
into which were glued 1 ml or 5 ml plastic test tubes,
as described [19,20]. Each well containing attached
cells was washed with 2 ml choline bu¡er (140 mM
choline chloride, 2 mM KCl, 1 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES-Tris, pH 7.4) to remove me-
dium and serum, then the transport of 100 WM
[3H]succinate was measured in sodium bu¡er (same
as choline bu¡er but with 140 mM sodium in place
of choline) for 15 min. Succinate transport is linear
through 15 min in COS-7 cells expressing pSV-201
[18]. The dishes were placed on a rocker during the
incubation period after which the transport solution
was poured o¡. The uptakes were stopped with three
2 ml washes of ice-cold choline bu¡er and the re-
maining bu¡er was aspirated o¡. The cells were
then lysed in 250 Wl of 0.1% sodium dodecyl sulfate
(SDS). Half of each lysed cell sample (125 Wl) was
used for scintillation counting and the rest was used
for measurement of protein concentration with the
Detergent Compatible (DC) Protein Assay kit (Bio-
Rad).
2.4. Cell surface and total cell biotinylation of
COS-7 cells
The cell surface and total cell expression of NaDC-
1 and Flag-NaDC-1 was tested by biotinylation with
a membrane impermeant reagent, Sulfo-NHS-LC-
Biotin (Pierce), followed by streptavidin precipitation
and immunoblotting, a method similar to that de-
scribed in our previous study with Xenopus oocytes
[15]. The transfected COS-7 cells grown in six-well
plates were detached from the culture dish with 1 ml
0.4% trypsin for 5 min at 37‡C, followed by the
addition of 1 ml culture medium (D-MEM contain-
ing serum and antibiotics). Three wells were com-
bined for each group. The suspended cells were
rinsed three times with 1 ml ice-cold PBS bu¡er,
pH 8, and surface biotinylated by incubating cells
with 0.5 mg/ml Sulfo-NHS-LC-Biotin in 0.5 ml
PBS bu¡er, pH 8, for 30 min at room temperature.
The biotinylation reagent was removed with two
washes with ice-cold PBS, pH 8. The cells were
then dissolved in 50 Wl lysis bu¡er (150 mM NaCl,
20 mM Tris-HCl pH 7.6, 1% (v/v) Triton X-100) for
30 min on ice. For measurement of total cell biotin-
ylation the cells were lysed before incubation with
biotinylation reagent. After biotinylation and solubi-
lization, the cells were centrifuged for 15 min at
14 000Ug and the supernatants were transferred to
new tubes. The biotinylated proteins were incubated
with 50 Wl Immunopure Immobilized Streptavidin
(Pierce) on a rocker for 1 h at 4‡C. The biotin-strept-
avidin-agarose bead complexes were then washed
four times with lysis bu¡er and the ¢nal pellets
were resuspended in SDS-PAGE sample bu¡er [21].
2.5. Western blots
The NaDC-1 and Flag-NaDC-1 transporters were
detected in the pool of biotinylated proteins using
Western blotting, as described previously [21]. The
polyclonal anti-NaDC-1 antibodies used in this study
were raised in rabbits and directed against a fusion
protein containing amino acids 164^233, from hydro-
philic loop 4 of NaDC-1 [15,22]. The primary anti-
body was used at 1/5000 dilution and the secondary
antibody, horseradish peroxidase linked anti-rabbit
Ig (Amersham), was used at 1/2000 dilution. The
mouse monoclonal M5 anti-Flag antibody (Sigma)
was tested at 1/500 dilution, but did not produce
any signal in Western blots (results not shown). Anti-
body binding was visualized by enhanced chemilumi-
nescence using the Supersignal CL-HRP substrate
system (Pierce).
2.6. Permeabilization of cells grown on glass
coverslips
For immuno£uorescence studies, some of the
COS-7 cells grown on glass coverslips were permea-
bilized using digitonin [23,24]. The cell monolayers
were washed three times with ice-cold KHM bu¡er
(110 mM K-acetate, 2.5 mM Mg-acetate, 20 mM
HEPES, pH 7.2), followed by 4 min incubation
with ice-cold 20 Wg/ml digitonin (Sigma) dissolved
in KHM bu¡er. The digitonin was removed by wash-
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ing the cells twice with 5 ml ice-cold PBS bu¡er (137
mM NaCl, 2.7 mM KCl, 6.5 mM Na2HPO4, 1.5 mM
KH2PO4, 0.9 mM CaCl2, 0.5 mM MgCl2, pH 7.4).
The optimal concentration of digitonin was deter-
mined by incubating the COS-7 cells with digitonin
concentrations ranging from 5 Wg/ml to 100 Wg/ml
and examining the percentage of cells staining with
4% trypan blue. The cells were considered to be com-
pletely permeabilized when more than 90% were
stained with trypan blue.
2.7. Immuno£uorescent staining
The permeabilized and non-permeabilized COS-7
cells on glass coverslips were used for immuno£uo-
rescent staining with the anti-NaDC-1 and M5 anti-
Flag antibodies. Prior to staining, cells were incu-
bated for 1 h with blocking bu¡er consisting of D-
MEM cell culture medium with 1% goat serum. The
cell monolayers were then incubated for 2 h with
primary antibody (1/500 dilution of anti-NaDC-1
or M5 anti-Flag antibody in blocking bu¡er) and 1 h
with secondary antibody (1/1000 dilution of FITC-
conjugated anti-rabbit IgG antibody or anti-mouse
IgG antibody (Molecular Probes)). The cell mono-
layers were washed three times with 5 ml PBS bu¡er
after each antibody incubation. Control experiments
examining trypan blue exclusion showed that the
cells were not permeabilized by the washes and anti-
body incubations (results not shown). Finally, the
cells were ¢xed with 1% formaldehyde in PBS bu¡er
for 1 h and mounted with FluorSave reagent (Cal-
biochem).
Fluorescent staining of the cell monolayers was
visualized with a Nikon epi£uorescence microscope
(Model Eclipse E800, Japan). Fluorescence signals
were obtained using band pass ¢lters at 480 nm
and 535 nm for the excitation and emission paths,
respectively. Images were taken through a digital vid-
eo camera (Dage CCD 300T, Dage MTI) and re-
corded and analyzed with MetaMorph imaging soft-
ware (MetaMorph v. 3.5, Universal Imaging, PA).
Both phase-contrast and £uorescent images were tak-
en for every given ¢eld of cells, which contained at
least 5^10 cells.
Fig. 1. Transport of succinate in COS-7 cells transfected with
plasmid pSV-SPORT1 (control), pSV-201 (coding for NaDC-1)
or pSV-201-Flag (coding for Flag-NaDC-1). The uptake of 100
WM succinate was measured for 15 min in sodium-containing
bu¡er. The data shown represent means þ ranges of duplicate
wells.
Fig. 2. Immunoblot analysis of NaDC-1 and Flag-NaDC-1 ex-
pressed in COS-7 cells. COS-7 cells transfected with pSV-
SPORT1, pSV-201 or pSV-201-Flag were biotinylated with a
membrane impermeant reagent, Sulfo-NHS-LC-Biotin, before
cell lysis (cell surface biotinylation) or after cell lysis (total cell
biotinylation). The biotinylated proteins were precipitated with
streptavidin-agarose beads and separated using SDS-PAGE.
The separated proteins were transferred to nitrocellulose,
probed with the anti-NaDC-1 antibody and visualized with en-
hanced chemiluminescence. The position of size standards
(Benchmark Prestained size standards, Gibco/BRL) is shown at
left.
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3. Results
3.1. Expression of NaDC-1 and Flag-NaDC-1 in
COS-7 cells
The cell surface expression of NaDC-1 and Flag-
NaDC-1 was monitored by measurement of succi-
nate transport activity. As shown in Fig. 1, COS-7
cells transiently transfected with plasmids pSV-201
(coding for NaDC-1) and pSV-201-Flag (coding for
Flag-NaDC-1) exhibited transport of succinate that
was higher than the transport in control cells trans-
fected with pSV-SPORT1 vector only. The uptake
rate of cells expressing NaDC-1 is similar to that
seen in our previous study, approx. 100 pmol/mg
protein per min, and the background transport in
control cells is somewhat lower [18]. The rate of suc-
cinate transport in cells expressing Flag-NaDC-1 was
approx. 50% of that in cells expressing the wild-type
NaDC-1 (Fig. 1).
Western blots of NaDC-1 expressed in COS-7 cells
show two predominant protein bands at approx. 58
and 75 kDa, which probably represent di¡erently
glycosylated forms of the transporter (Fig. 2), similar
to what is seen in Xenopus oocytes [21]. The control
COS-7 cells transfected with the control plasmid
pSV-SPORT have two sharp protein bands that react
with the antibodies, suggesting some cross-reactivity
of the antibodies with proteins in the COS-7 cells.
Similar to the results of transport assays, the cell
surface abundance of Flag-NaDC-1 protein was low-
er than that of wild-type NaDC-1 (Fig. 2). Although
the transport activity of Flag-NaDC-1 (Fig. 1) ap-
pears to be higher than the relative protein abun-
dance, it should be noted that the uptakes are nor-
malized for protein content, which decreased in the
Flag-NaDC-1 groups, whereas the biotinylations
compare wells of cells. Possibly the expression of
Flag-NaDC-1 protein is more toxic to the cells.
When the wells of cells are compared, the transport
Fig. 3. Phase-contrast images of COS-7 cells grown on glass coverslips. (A) Non-permeabilized COS-7 cells ; (B) non-permeabilized
COS-7 cells treated with trypan blue dye; only one cell has taken up the dye; (C) COS-7 cells permeabilized with 20 Wg/ml digitonin;
(D) permeabilized COS-7 cells treated with trypan blue; most of the cell nuclei have taken up the dye.
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activity of Flag-NaDC-1 is about 35% of the NaDC-
1 group. Fig. 2 also shows that the total cell abun-
dance of Flag-NaDC-1 protein is similar to the
NaDC-1 protein. Therefore, the results indicate
that Flag-NaDC-1 is expressed functionally on the
plasma membrane of COS-7 cells but the presence
of the Flag epitope at the N-terminus a¡ects the
tra⁄cking or cell surface stability of the protein.
Fig. 4. Immuno£uorescence and phase-contrast images of COS-7 cells treated with anti-NaDC-1 antibodies followed by FITC-conju-
gated secondary antibodies. The left column (A1^D1) shows phase-contrast images and the right column (A2^D2) shows the corre-
sponding £uorescent images of the same microscopic ¢eld. Samples: (A) non-permeabilized COS-7 cells transfected with pSV-SPORT1
control vector; (B) non-permeabilized COS-7 cells transfected with pSV-201; (C) digitonin-permeabilized COS-7 cells transfected with
pSV-SPORT1 control vector; (D) permeabilized COS-7 cells transfected with pSV-201.
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Fig. 5. Immuno£uorescence and phase-contrast images of COS-7 cells treated with M5 anti-Flag antibodies followed by FITC-conju-
gated secondary antibodies. The left column (A1^D1) shows phase-contrast images and the right column (A2^D2) shows the corre-
sponding £uorescent images of the same microscopic ¢eld. Samples: (A) non-permeabilized COS-7 cells transfected with pSV-SPORT1
control vector; (B) non-permeabilized COS-7 cells transfected with pSV-201-Flag; (C) digitonin-permeabilized COS-7 cells transfected
with pSV-SPORT control vector; (D) permeabilized COS-7 cells transfected with pSV-201-Flag.
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3.2. Digitonin permeabilization of COS-7 cells grown
on coverslips
The optimal conditions for cell permeabilization
were determined by incubating COS-7 cells for
4 min with di¡erent concentrations of digitonin rang-
ing from 5 to 100 Wg/ml. The lowest concentration of
digitonin that produced more than 90% staining with
trypan blue was 20 Wg/ml, and this concentration was
used in subsequent experiments. As shown in Fig. 3,
almost all of the cells treated with 20 Wg/ml digitonin
were stained with trypan blue.
3.3. Localization of amino acids 164^233
Rabbit polyclonal antibodies raised against amino
acids 164^233 of NaDC-1 were used to determine the
cellular location of hydrophilic loop 4. The phase-
contrast and £uorescent images from a single experi-
ment are shown in Fig. 4. The highest intensity im-
muno£uorescent signal was seen in cells expressing
NaDC-1, but only when the cell membranes were
permeabilized with digitonin (Fig. 4B2 vs. D2). Ap-
prox. 40^50% of the permeabilized cells transfected
with pSV-201 had £uorescence signals that were
higher than control cells, indicating a cell transfec-
tion e⁄ciency of at least 40%. Intact cells had little
or no immuno£uorescence. There was some £uores-
cence associated with nuclei in some experiments
with permeabilized cells transfected with the control
plasmid, pSV-SPORT1 (Fig. 4C2), but the £uores-
cence intensity was much lower than that seen in cells
transfected with pSV-201. The immuno£uorescence
was not seen in cells incubated with secondary anti-
body only (results not shown). Therefore, the epitope
for the anti-NaDC-1 antibodies is located intracellu-
larly.
3.4. Localization of the N-terminus
The M5 anti-Flag monoclonal antibody was used
to detect the Flag peptide fused to the N-terminus of
NaDC-1 (Flag-NaDC-1). Similar to the results with
the anti-NaDC-1 antibodies, immunostaining was
only positive in COS-7 cells that were both permea-
bilized and transfected with pSV-201-Flag (Fig.
5D2). Approx. 20% of the permeabilized cells trans-
fected with pSV-201-Flag showed immuno£uores-
cence above controls, which indicates a lower
amount of protein expression or lower transfection
e⁄ciency with the pSV-201-Flag plasmid. There was
no immunostaining in intact cells and only occasion-
al immunostaining of nuclei in permeabilized cells
transfected with the control plasmid, pSV-SPORT1.
The positive staining was also not due to the FITC-
conjugated anti-mouse secondary antibody (not
shown). The results of these experiments show that
the N-terminus of NaDC-1 is located intracellularly.
4. Discussion
The secondary structure model of NaDC-1 was
originally based on an analysis of the amino acid
sequence using the Rao-Argos buried helix parame-
ter scale [15]. This model of NaDC-1 contains 11
membrane-spanning K-helices and the N- and C-ter-
mini on opposite sides of the membrane. The only
experimental veri¢cation of this model prior to this
study has come from the identi¢cation of the N-gly-
cosylation site at Asn-578, which places the C-termi-
nus on the extracellular side of the plasma membrane
[15]. The results of this study are in agreement with
the current model of NaDC-1, with the N-terminus
Fig. 6. Secondary structure model of NaDC-1. The open rec-
tangles represent 11 transmembrane K-helices joined by hydro-
philic loops. The Y indicates the N-glycosylation site at the C-
terminus. The heavy line in hydrophilic loop 4, between trans-
membrane domains 4 and 5, shows the location of amino acids
163^233 used to produce the anti-NaDC-1 antibodies. The gray
rectangle represents the Flag peptide fused to the N-terminus of
NaDC-1.
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and hydrophilic loop 4 both located inside the cell
(Fig. 6).
The anti-NaDC-1 antibodies used in this study
were raised against a fusion protein of amino acids
164^233 of NaDC-1 and glutathione S-transferase
[15]. The sequence of amino acids 164^233 is very
hydrophilic, containing 16 charged amino acids. Ac-
cording to our model of NaDC-1, this peptide is
located in hydrophilic loop 4 between transmem-
brane domains 4 and 5. Since it was possible to iden-
tify an immuno£uorescent signal in cells expressing
NaDC-1, it is likely that the epitope for the anti-
NaDC-1 antibodies is exposed rather than being
buried in the membrane. Furthermore, the £uores-
cence signal was dependent on the permeabilization
of the cell membrane to allow the antibodies access
to the inside of the cell. Therefore, the results sup-
port our current secondary structure model.
To detect the location of the N-terminus of
NaDC-1, a fusion protein was made containing the
epitope of the Flag antibody at the N-terminus of
NaDC-1. This fusion protein was detected using
the M5 anti-Flag antibody. The addition of the
Flag epitope did not appear to a¡ect the function
of NaDC-1, although it did result in lower cell sur-
face protein expression. Cells expressing the Flag-
NaDC-1 fusion protein showed immuno£uorescent
staining only after the cell membranes had been per-
meabilized with digitonin, consistent with the predic-
tion that the N-terminus of NaDC-1 is intracellular.
In addition, since both the N-terminus and hydro-
philic loop 4 are located on the same side of the
membrane, the results indicate that there are an
even number of transmembrane domains between
them.
It is likely that all of the members of the family
related to NaDC-1 have very similar protein struc-
tures. The mammalian members of the SLC13 super-
family have approximately the same number of ami-
no acids (594^602 amino acids) and, when analyzed
using the same method, the hydropathy plots are
virtually superimposable. All of the members of
this family contain a conserved N-glycosylation site
at the C-terminus [1]. However, there is considerable
variation in the secondary structural models that
have been proposed for the members of this family,
probably because the C-terminal half of the protein
is very hydrophobic. For example, the £ounder high
a⁄nity Na/dicarboxylate cotransporter, fNaDC-3,
is predicted to have eight transmembrane domains
[16], the rat NaDC-1 is predicted to have 12 [9],
and the mouse Na/sulfate cotransporter, mNaSi-1,
is thought to have 13 [13]. However, none of these
models has been tested experimentally. Since the re-
sults of this study show that NaDC-1 has an odd
number of transmembrane domains, it is likely that
the eight and 12 transmembrane domain models for
the other family members are incorrect. Further
studies will be required to re¢ne the secondary struc-
ture model.
In conclusion, the N-terminus and hydrophilic
loop 4 of the Na/dicarboxylate cotransporter,
NaDC-1, are both located on the cytoplasmic side
of the cell membrane. The results of this study sup-
port our current secondary structure model of
NaDC-1 with 11 transmembrane domains, an intra-
cellular N-terminus and an extracellular C-terminus.
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